地方会予定 | 日本循環器学会 関東甲信越支部
日本循環器学会関東甲信越支部のホームページです
Related Articles
The Current and Future State of Medical Education – with Dr. Conrad Fischer and Dr. Jason Ryan
Here we discuss the current and future state of medical education as well as the exciting collaborative project Dr. Fischer and Dr. Ryan plans to…
Go Red For Women | AHA Journals
This collection highlights some of the latest research on cardiovascular disease in women from across the AHA portfolio of journals.
Vivid Talk Webinar: Incorporating 4D imaging into your cardiac ultrasound – the what, why and when.
Thursday, February 13, 2025 at 7:30 PM Australian Eastern Daylight Time (Victoria).
Author Hub | AHA/ASA Journals
Rigorous, dependable research has always been at the core of the American Heart Association (AHA) mission to be a relentless force for a world of…
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation | Journal of the American Heart Association
BackgroundCardiac biomarkers improve risk prediction in patients with atrial fibrillation (AF). We recently demonstrated that the NFL (neuron‐specific protein neurofilament light chain) was associa…
Where Heart Failure and Interventional Cardiology Intersect
Jennifer Rymer and Srihari Naidu say now is the time for both subspecialties to learn from one another, embrace new technologies, and fill some evidence…
Post-MI Risk of Incident HF Higher Than Risk of Recurrent MI – American College of Cardiology
The risk of incident heart failure (HF) after a myocardial infarction (MI) is up to six-fold higher than the risk of recurrent MI and the…
Dr. Huo ISC25 LB38 adding clot-busting injection
Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being…
Dr. Lou ISC25 LB41 extending treatment benefits
Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the…